Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Gross Margin (2016 - 2024)

Historic Gross Margin for Regenxbio (RGNX) over the last 11 years, with Q4 2024 value amounting to 70.22%.

  • Regenxbio's Gross Margin rose 208100.0% to 70.22% in Q4 2024 from the same period last year, while for Dec 2024 it was 59.72%, marking a year-over-year increase of 9500.0%. This contributed to the annual value of 59.72% for FY2024, which is 9500.0% up from last year.
  • Regenxbio's Gross Margin amounted to 70.22% in Q4 2024, which was up 208100.0% from 48.81% recorded in Q3 2024.
  • In the past 5 years, Regenxbio's Gross Margin registered a high of 94.22% during Q4 2021, and its lowest value of 29.26% during Q1 2022.
  • Moreover, its 5-year median value for Gross Margin was 58.19% (2022), whereas its average is 62.32%.
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -450500bps in 2022, then soared by 492500bps in 2023.
  • Over the past 5 years, Regenxbio's Gross Margin (Quarter) stood at 52.17% in 2020, then skyrocketed by 81bps to 94.22% in 2021, then plummeted by -37bps to 59.22% in 2022, then dropped by -17bps to 49.41% in 2023, then surged by 42bps to 70.22% in 2024.
  • Its last three reported values are 70.22% in Q4 2024, 48.81% for Q3 2024, and 52.55% during Q2 2024.